Companies / Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd
Nasdaq: CNTBCIK 1835268SAN DIEGO, CA
Financials · FY2025
Ownership
63.0M shares outstanding · as of Jul 31, 2026
Ownership
| Public float | 100.00% | 62,974,309 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Huang JamesDirector | — | — |
Liu Jean IDirector | — | — |
Peraza LisaSenior Vice President, Finance | — | — |
Quart Barry DCEOChief Executive Officer · Director | — | — |
Schoeneck James ADirector | — | — |
Szekeres David LesliePresident | — | — |
Wilson Karen JDirector | — | — |
Xanthopoulos Kleanthis GabrielDirector | — | — |
Institutional holders 0
| Holder | Value | % of shares |
|---|---|---|
| No institutional holders on file. | ||
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Liu Jean I Director | Grant | Ordinary Shares | $0 | +5K | 5,061 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Ikarian Capital, LLC | Passive13G | — |
| Zheng Wei | Passive13G/A | — |
| BioFortune Inc. | Passive13G/A | — |